NCT00254475
- Conditions
- Cardiovascular Diseases, Dyslipidemias, Essential Hypertension, +7 more
- Locations
-
- Investigative Centers, Germany
- Novartis Pharmaceuticals Basel, Switzerland
Clinical trial condition
Explore clinical trials studying Essential Hypertension. Study availability and eligibility vary by location and protocol.
NCT00254475
NCT01631227
NCT01679652
NCT01113047
NCT01842256
NCT01842230
NCT01900184
NCT01900171